DENTSPLY SIRONA (NASDAQ:XRAY) Releases FY 2024 Earnings Guidance

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) updated its FY 2024 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 2.000-2.100 for the period, compared to the consensus estimate of 2.060. The company issued revenue guidance of $3.9 billion-$4.0 billion, compared to the consensus revenue estimate of $4.0 billion.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on XRAY shares. Evercore ISI dropped their price objective on shares of DENTSPLY SIRONA from $40.00 to $35.00 and set an outperform rating on the stock in a research note on Friday. SVB Leerink assumed coverage on DENTSPLY SIRONA in a research note on Monday, February 26th. They set an outperform rating and a $42.00 price target for the company. StockNews.com raised shares of DENTSPLY SIRONA from a hold rating to a buy rating in a report on Friday, January 19th. Needham & Company LLC lowered their price target on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a buy rating on the stock in a research report on Friday. Finally, Robert W. Baird cut their price objective on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a neutral rating for the company in a report on Friday. Four investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of Moderate Buy and an average target price of $36.90.

DENTSPLY SIRONA Trading Down 0.3 %

XRAY stock traded down $0.09 during trading on Friday, hitting $28.29. 4,506,596 shares of the company traded hands, compared to its average volume of 3,342,785. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.95 and a current ratio of 1.38. The company has a 50-day moving average of $32.24 and a 200-day moving average of $32.73. The firm has a market capitalization of $5.87 billion, a PE ratio of -45.43, a P/E/G ratio of 1.22 and a beta of 1.00. DENTSPLY SIRONA has a 1 year low of $26.27 and a 1 year high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.42. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. The company had revenue of $953.00 million for the quarter, compared to the consensus estimate of $969.45 million. During the same quarter in the previous year, the business earned $0.39 EPS. DENTSPLY SIRONA's revenue was down 2.6% compared to the same quarter last year. Analysts predict that DENTSPLY SIRONA will post 2.05 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were paid a dividend of $0.16 per share. This is an increase from DENTSPLY SIRONA's previous quarterly dividend of $0.14. The ex-dividend date was Wednesday, March 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.26%. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -103.22%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.